[{"arm_notes": "", "treatment_id": null, "treatment_name": "Abdala - protein subunit COVID-19 vaccine (RBD 50 mcg + 0.30 mg aluminum hydroxide): 0.5 mL intramuscularly in the deltoid region (schedule 0-14-28 days).;Immunogenicity; Vaccine;Immunotherapy; Active;Vaccination;Injections; Intramuscular;Vaccine Abdala", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1975, "treatment_name": "Cigb-66", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}]